Working… Menu

A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03315507
Recruitment Status : Completed
First Posted : October 20, 2017
Last Update Posted : October 8, 2019
Information provided by (Responsible Party):
PhaseBio Pharmaceuticals Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 8, 2019
Actual Study Completion Date : August 8, 2019